Stock listing
Gc Biopharma Corp.
Selected listing: 006280 · KRX · KRW · KR
Gc Biopharma Corp. (KRX:006280), Health Technology. Latest release Aug 24, 2026: GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval…
- Ticker
- KRX:006280
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Gc Biopharma Corp.
Gc Biopharma Corp. is a public company listed on the Korean market under the ticker 006280. Gc Biopharma specializes in biopharmaceuticals, focusing on the development and production of innovative therapies.
Latest news from Gc Biopharma Corp.
GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan
August 24, 2026
GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
May 4, 2026
GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
April 16, 2026
GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
April 6, 2026
GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala
March 26, 2026